RichardThomasDaveyJr.MD

Infectious Disease • Bethesda, MD

Physician

Join to view full profile

Dr. Davey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Davey's full profile

Already have an account?

Office
10 Rockville Pike
Bethesda, MD 20892
Phone+1 301-496-8029

Fax+1 301-480-5560

Education & Training

National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1984 - 1987
Boston University Medical CenterResidency, Internal Medicine, 1980 - 1983
Columbia University Vagelos College of Physicians and SurgeonsClass of 1980

Certifications & Licensure

MD State Medical License 1984 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies Start of enrollment: 1984 Jan 09
Recruiting
Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies Start of enrollment: 2003 Dec 01
Completed
Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study Start of enrollment: 2008 Mar 24
Completed
Phase 1
Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases Start of enrollment: 2011 Aug 04
Recruiting
DAS181 in Patients With Parainfluenza Start of enrollment: 2011 Jul 14
Withdrawn
Phase 2
Testing the AVI-7100 Flu Drug in Healthy Volunteers Start of enrollment: 2012 Dec 08
Completed
Phase 1
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects Start of enrollment: 2014 Jan 03
Withdrawn
Phase 1
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products Start of enrollment: 2023 Apr 24
Recruiting
Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults Start of enrollment: 2016 May 28
Completed
Phase 1
Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure Start of enrollment: 2016 Oct 14
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Vector induced humoral responses after rVSVΔG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodies.
Prabha Chandrasekaran, Irina Maljkovic Berry, Viviane Callier, Scott M Anthony, Krystle Hensley
The Journal of Infectious Diseases. 2024-12-24
Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study.
Daniel Mukadi-Bamuleka, François Edidi-Atani, Maria E Morales-Betoulle, Anaïs Legand, Antoine Nkuba-Ndaye
The Lancet. Microbe. 2024-10-01
2 citations
Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19.
Shreya M Kanth, Julio A Huapaya, Salina Gairhe, Honghui Wang, Xin Tian
Cell Reports. Medicine. 2024-07-16

Journal Articles

Safety, Tolerability, and Pharmacokinetics of Radavirsen (AVI‐7100), an Antisense Oligonucleotide Targeting Influenza a M1/M2 Translation
Richard T Davey, John H Beigel, British Journal of Clinical Pharmacology

Grant Support

Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2009–2011
Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2009–2011
Influenza And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2007–2008
Immunologic And Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2007–2008
Immunologic And Virologic Approaches To HIV-1 TherapeutiNational Institute Of Allergy And Infectious Diseases2002–2006
Immunologic/Virologic Approaches To HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2005
Immunologic &Virologic Approaches To HIV 1 TherapeuticsNational Institute Of Allergy And Infectious Diseases2001
Immunologic And Virologic Approaches To HIV1 TherapeuticNational Institute Of Allergy And Infectious Diseases2000